ATE99298T1 - 1,4,8-triazacyclotridecan-derivate mit prolylendopeptidase-hemmender wirkung. - Google Patents

1,4,8-triazacyclotridecan-derivate mit prolylendopeptidase-hemmender wirkung.

Info

Publication number
ATE99298T1
ATE99298T1 AT91104163T AT91104163T ATE99298T1 AT E99298 T1 ATE99298 T1 AT E99298T1 AT 91104163 T AT91104163 T AT 91104163T AT 91104163 T AT91104163 T AT 91104163T AT E99298 T1 ATE99298 T1 AT E99298T1
Authority
AT
Austria
Prior art keywords
triazacyclotridecan
prolylene
derivatives
inhibitor activity
endopeptidase inhibitor
Prior art date
Application number
AT91104163T
Other languages
English (en)
Inventor
Toda Soichiro
Oki Toshikazu
Hamagishi Yasutaro
Tomita Koji
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE99298T1 publication Critical patent/ATE99298T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D255/00Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91104163T 1990-03-22 1991-03-18 1,4,8-triazacyclotridecan-derivate mit prolylendopeptidase-hemmender wirkung. ATE99298T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/497,292 US4999349A (en) 1990-03-22 1990-03-22 BU-4164E - A and B, prolyl endopeptidase inhibitors

Publications (1)

Publication Number Publication Date
ATE99298T1 true ATE99298T1 (de) 1994-01-15

Family

ID=23976256

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91104163T ATE99298T1 (de) 1990-03-22 1991-03-18 1,4,8-triazacyclotridecan-derivate mit prolylendopeptidase-hemmender wirkung.

Country Status (7)

Country Link
US (1) US4999349A (de)
EP (1) EP0451547B1 (de)
JP (1) JPH06339390A (de)
AT (1) ATE99298T1 (de)
CA (1) CA2038509A1 (de)
DE (1) DE69100865D1 (de)
DK (1) DK0451547T3 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073549A (en) * 1990-03-22 1991-12-17 Bristol-Myers Squibb Company BU-4164E - A and B, prolyl endopeptidase inhibitors and their methods of use
GB9024208D0 (en) * 1990-11-07 1990-12-19 Salutar Inc Compounds
CA2089890A1 (en) * 1991-06-20 1992-12-21 Makoto Yoshihama Prolyl endopeptidase inhibitors sna-115 and sna-115t, production thereof, and strain which produces said inhibitors
WO2002010142A1 (en) * 2000-08-02 2002-02-07 Slil Biomedical Corporation Cyclic polyamine compounds for cancer therapy
US20030072715A1 (en) * 2000-08-02 2003-04-17 Benjamin Frydman Cyclic polyamine compounds for cancer therapy
WO2004098591A2 (en) 2003-05-05 2004-11-18 Probiodrug Ag Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
ZA200603165B (en) 2003-11-03 2007-07-25 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
AU2005210004B2 (en) 2004-02-05 2010-10-28 Probiodrug Ag Novel inhibitors of glutaminyl cyclase
EP2089383B1 (de) 2006-11-09 2015-09-16 Probiodrug AG 3-hydroxy-1,5-dihydropyrrol-2-one derivate als inhibitoren von glutaminylcyclase zur behandlung von geschwüren, krebs und anderen krankheiten
SI2091948T1 (sl) 2006-11-30 2012-07-31 Probiodrug Ag Novi inhibitorji glutaminil ciklaze
JP5930573B2 (ja) 2007-03-01 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤の新規使用
EP2142514B1 (de) 2007-04-18 2014-12-24 Probiodrug AG Thioharnstoffderivate als glutaminylcyclaseinhibitoren
WO2008144748A1 (en) * 2007-05-21 2008-11-27 The Uab Research Foundation Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation
SG178953A1 (en) 2009-09-11 2012-04-27 Probiodrug Ag Heterocylcic derivatives as inhibitors of glutaminyl cyclase
EP2542549B1 (de) 2010-03-03 2016-05-11 Probiodrug AG Glutaminylcyclase-hemmer
WO2011110613A1 (en) 2010-03-10 2011-09-15 Probiodrug Ag Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
US8530670B2 (en) 2011-03-16 2013-09-10 Probiodrug Ag Inhibitors
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6137764A (ja) * 1984-07-31 1986-02-22 Suntory Ltd 抗プロリルエンドペプチダ−ゼ活性を有する新規生理活性化合物
DE3684633D1 (de) * 1985-04-16 1992-05-07 Suntory Ltd Dipeptid-derivate von fettsaeure, verfahren zu ihrer herstellung, heilmittel, das sie enthaelt und anwendung.
JPH0623190B2 (ja) * 1985-04-16 1994-03-30 サントリー株式会社 インヒビタ−活性を有するn−アシルピロリジン誘導体及びその製法並びに用途
US4898940A (en) * 1985-08-30 1990-02-06 Bristol-Myers Company Peptide antibiotics
JPH0764834B2 (ja) * 1985-11-29 1995-07-12 サントリー株式会社 プロリルエンドペプチダーゼ阻害活性を有する新規ピロリジンアミド誘導体およびその製法並びに用途
CA1320734C (en) * 1986-02-04 1993-07-27 Suntory Limited Pyrrolidineamide derivative of acylamino acid and pharmaceutical composition containing the same
JPH08806B2 (ja) * 1986-11-18 1996-01-10 サントリー株式会社 プロリルエンドペプチダ−ゼ阻害作用を有する新規ピロリジンアミド誘導体
ATE151760T1 (de) * 1987-02-23 1997-05-15 Ono Pharmaceutical Co Thiazolidin-derivate
US4857524A (en) * 1987-08-08 1989-08-15 Kissei Pharmaceutical Co., Ltd. Thiazolidine compounds and therapeutic method

Also Published As

Publication number Publication date
EP0451547B1 (de) 1993-12-29
US4999349A (en) 1991-03-12
DK0451547T3 (da) 1993-12-29
CA2038509A1 (en) 1991-09-23
JPH06339390A (ja) 1994-12-13
DE69100865D1 (de) 1994-02-10
EP0451547A1 (de) 1991-10-16

Similar Documents

Publication Publication Date Title
ATE99298T1 (de) 1,4,8-triazacyclotridecan-derivate mit prolylendopeptidase-hemmender wirkung.
AU1642795A (en) Substituted pyridylpyrazoles
EP0245518A4 (de) Isoflavon-abkömmlinge, salze dazu sowie onkostatische und immunsuppressive mittel.
DK0572166T3 (da) Hidtil ukendte 7beta-substitueret-4-aza-5beta-androstan-3-oner som 5beta-reduktaseinhibitorer
DK0706393T3 (da) Immun-undertrykkende og antiallergiske forbindelser, f.eks. N-(3-oxohexanoyl)homoserin-lacton
ATE267164T1 (de) 9-(substituiertes glycyl)amido-6-(substituiert)-5-hydroxy-6-deoxy etracycline
FI954979A7 (fi) Kemoherkistävinä aineina käytettävät 10,11-metanodibentsosuberaanijohdannaiset
DK0582829T3 (da) 9-(Substitueret glycyl)amido-6-demethyl-6-deoxytetracycliner som antibiotiske midler
NL1002835A1 (nl) Synergistisch stabilisatormengsel.
ATE338744T1 (de) Hydrazonderivate
FI962022A7 (fi) 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraali sina aineina
NO944406L (no) Nye 7 e inhibitorer
PT843679E (pt) Derivados da1-(piperidinil 1,2-disubstituido)-(4-imidazole fundido)-piperidina
KR950704257A (ko) 매트릭스 메탈로프로테이나제 억제제로서의 카보스티릴 유도체(Carbostyril derivatives as matrix metalloproteinases inhibitors)
FI962021A7 (fi) 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraali sina aineina
ATE142226T1 (de) Balhimycin-abgeleitete glykopeptidische antibiotika
RU94014631A (ru) Производные 4-хиномиодигидропиридина, смесь их изомеров или отдельные изомеры и их соли
ES2054927T3 (es) Antibioticos glicosidicos bu-3608 d y bu-3608 e.
AU665648B2 (en) Azacycloalkane derivatives
AU2873692A (en) Nitroxyalkylamide derivatives
FI931794L (fi) Monokvaternaera 2,16-bispiperidinylandrostanderivat
KR950700297A (ko) 5-HT3-수용체 길항제로서의 2,6-메타노-2H-퀴놀리진 유도체(2,6-Methano-2H-quinolizin derivative as 5-HT3-receptor antagonist)
ES2116399T3 (es) Derivados tiazolicos de alcoxiacrilatos con una actividad fungicida.
DE58903780D1 (de) N-substituierte 3,4,5,6-tetrahydrophthalimid-derivate.
EP0617000A3 (de) 4-Fluorobiphenylderivate.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties